Not Tagged
roche,blueprint medicines
['blueprint medicine', 'blueprint ']
#ash22: a mutation in the kit receptor, kit d816v, is the underlying disease driver in about 95% of systemic #mastocytosis cases. this can lead to the uncontrolled proliferation &amp; activation of mast cells, which can cause debilitating &amp; often unpredictable symptoms. read more:
Blueprint Medicines is a precision therapy company that invents life-changing medicines for cancer and blood disorders. Our guidelines: https://t.co/wupWRI5a30